1 of damaged telomeres, can be explained from
this viewpoint.
2 disease trials of relevance are discussed in
this viewpoint.
3 ngham study was instrumental in establishing
this viewpoint.
4 ons have special considerations discussed in
this Viewpoint.
5 cribed in the Featured Article summarized in
this Viewpoint.
6 ng the premalignant conditions considered in
this Viewpoint.
7 to the discussion and approach described in
this Viewpoint.
8 ginality and relevance to the broad scope of
this viewpoint.
9 The studies reported here challenge
this viewpoint.
10 spects for limb regeneration in mammals from
this viewpoint.
11 In
this Viewpoint,
a panel of world-renowned MS specialists
12 This Viewpoint addresses the need for a centralized fine
13 This viewpoint aims at highlighting the potential applic
14 This Viewpoint aims to alleviate such doubts, pointing t
15 This viewpoint allows: (i) the full-blown integration of
16 This Viewpoint also includes experiences with regimens a
17 Given
this viewpoint,
an enzyme without its catalytic activity
18 This Viewpoint analyzes the process that will be used to
19 This Viewpoint applies a multilevel systems framework to
20 This Viewpoint argues for the routine inclusion of drink
21 This Viewpoint argues that not including the principle o
22 This Viewpoint article addresses the issues relevant to
23 This Viewpoint article briefly reviews evidence suggesti
24 This viewpoint article examines whether or not Staphyloc
25 Though
this Viewpoint article focuses on the symbioses among th
26 ugural entry in the new series Hidden Lives,
this Viewpoint Article highlights challenges in early ch
27 The purpose of
this Viewpoint article is to assess frailty and physical
28 This Viewpoint Article presents some of our research act
29 This Viewpoint Article shows how the psychological pheno
30 This viewpoint article summarizes the available evidence
31 This Viewpoint article summarizes the available evidence
32 To mark this anniversary, in
this Viewpoint article we asked a selection of researche
33 In
this Viewpoint article, 18 experts in the field tell us
34 d to share their stories with our readers in
this Viewpoint article, along with their opinions on how
35 In
this Viewpoint article, experts who participated in the
36 In
this Viewpoint article, five experts discuss our latest
37 In
this Viewpoint article, four leading scientists who have
38 In
this Viewpoint article, several experts in the field dis
39 In
this Viewpoint article, six patients and patient advocat
40 In
this Viewpoint article, we asked experts to share their
41 In
this Viewpoint article, we asked four experts for their
42 In
this Viewpoint article, we asked four experts for their
43 In
this Viewpoint article, we asked four scientists working
44 In
this Viewpoint Article, we discuss how the NMR community
45 In
this viewpoint article, we give a brief overview definit
46 In
this viewpoint article, we outline ways to apply a struc
47 In
this viewpoint article, we present an in-depth discussio
48 In
this Viewpoint Article, we share how early-career chemis
49 In
this viewpoint article, we summarize 2 expert workshops
50 In
this viewpoint article, we summarize the available liter
51 This Viewpoints article details our recommendation for t
52 This Viewpoints article on gender disparities in STEM of
53 This Viewpoints article outlines areas of consensus with
54 In
this Viewpoints article, we discuss critical variables t
55 In
this Viewpoints article, we show how recent data support
56 We respectfully offer
this viewpoint as a call to action to every reader to jo
57 This Viewpoint assesses recent developments in clonal ha
58 In
this Viewpoint,
authors from different urological subspe
59 This Viewpoint,
based primarily on unpublished data from
60 This Viewpoint briefly reviews the literature on sexual
61 This Viewpoint brings together insights from health syst
62 This is shown in
this Viewpoint by an in-depth comparison of the two stud
63 This viewpoint by the Society of Infectious Diseases Pha
64 t the inaccuracy of symptom-based screening,
this Viewpoint calls for removing symptom-based screenin
65 While moments of eye contact from
this viewpoint can be hand-coded, such a process tends t
66 Although we are aware that
this Viewpoint cannot provide full coverage of the vast
67 This Viewpoint compares and contrasts the circadian cloc
68 This Viewpoint compares key aspects of G protein signal
69 This Viewpoint compares the COVID-19 per capita overall
70 This Viewpoint conceptualises the work of the news media
71 This Viewpoint considers the implications of incorporati
72 This Viewpoint critically examines the current state of
73 This Viewpoint describes how we managed ethical issues o
74 This Viewpoint describes the discovery of inhibitors tar
75 This viewpoint describes the opinions of these organizat
76 This viewpoint discusses behavioral economic principles
77 This Viewpoint discusses the development trajectory of t
78 This Viewpoint discusses the unrealised potential of pal
79 This Viewpoint discusses these issues and highlights the
80 nt studies and randomized controlled trials,
this viewpoint document provides updated therapeutic ins
81 t of Cd-tolerant and biofortified cultivars,
this Viewpoint elaborates alternative approaches based o
82 This Viewpoint emphasises the importance of more nuanced
83 This Viewpoint evaluates management for pregnancies affe
84 This Viewpoint examines data on international trends in
85 This Viewpoint examines the intersectional challenges fa
86 In
this Viewpoint,
experts in the fields of medical therapy
87 This viewpoint explores strategies to address the health
88 This viewpoint explores the origins of the crisis and di
89 This Viewpoint explores the potential barriers and risks
90 In
this Viewpoint,
five experts from different regions disc
91 This Viewpoint focuses on Asia, where key populations ha
92 This Viewpoint focuses on issues that are important to c
93 This Viewpoint focuses on market shaping in low-income a
94 This viewpoint focuses on the need for and challenges of
95 This Viewpoint formulates and responds to three lines of
96 This Viewpoint highlights efforts to optimize anacetrapi
97 This Viewpoint highlights several examples of basic rese
98 This viewpoint highlights some useful characteristics of
99 This Viewpoint highlights the opportunities and challeng
100 This Viewpoint highlights these sex differences, gaps in
101 In
this Viewpoint,
I describe experiments supporting the vi
102 In
this Viewpoint,
I describe some of these exciting develo
103 In
this Viewpoint,
I will concentrate on the paradox of Sch
104 This Viewpoint is a global call for talaromycosis to be
105 The authors believe that
this viewpoint is incorrect, and is the result of misint
106 This viewpoint is supported by the temperature-dependent
107 The purpose of
this Viewpoint is to discuss the molecular design princi
108 The aim of
this Viewpoint is to highlight opportunities to rational
109 This Viewpoint issues a multidisciplinary call to embed
110 This viewpoint may also shift our perspective on individ
111 In
this Viewpoint,
Nature Reviews Immunology has invited si
112 This viewpoint offers a discussion of why testing-tracin
113 This viewpoint offers practical, experience-based guidan
114 This Viewpoint outlines a model of immunity based on the
115 This Viewpoint outlines the use of AI in both HIV and br
116 This Viewpoint outlines this general model, focusing on
117 In
this viewpoint paper, we summarize the available literat
118 From
this viewpoint,
positive and negative selection can be u
119 This Viewpoint presents a collective vision outlining pr
120 This viewpoint presents a framework for understanding th
121 As a step towards this goal,
this Viewpoint presents the experiences of 10 Black urol
122 This viewpoint presents the impact of COVID-19 on HIV ca
123 This Viewpoint proposes priority, programmatic, and poli
124 This Viewpoint provides a comprehensive perspective on h
125 its in large networks.SIGNIFICANCE STATEMENT
This viewpoint provides a concise overview on how to ext
126 This Viewpoint provides a way forward to resolve this im
127 This Viewpoint provides an integrated perspective on the
128 This viewpoint provides an overview of barriers to antib
129 Thus,
this Viewpoint provides guidelines conscious to biomedic
130 This viewpoint provides insight into the CLSI breakpoint
131 This Viewpoint provides researchers interested in commun
132 and limitations of symptom-based screening,
this Viewpoint questions whether the term helps or hinde
133 This Viewpoint raises concern at the failure to respond
134 In
this viewpoint,
rather than focusing on the downstream e
135 This viewpoint reflects on a selection of such high-impa
136 This Viewpoint represents a transition from simply highl
137 This Viewpoint reviews existing evidence and highlights
138 This Viewpoint seeks to highlight a great example of med
139 This Viewpoint seeks to place this molecule in the histo
140 This Viewpoint seeks to place this work in the wider con
141 e health policy and economic implications of
this viewpoint,
should it emerge in the management of co
142 These principles, as presented in
this Viewpoint,
show the applicability, opportunities, a
143 In
this Viewpoint,
six experts from different regions discu
144 In
this Viewpoint,
six experts present their opinions and c
145 In
this Viewpoint,
six rheumatology researchers at differen
146 Much of the work supporting
this viewpoint stems from studies focused on germinal ce
147 In
this Viewpoint,
Stephen Fry describes his prostate cance
148 This viewpoint suggests a natural statistic, which we de
149 This Viewpoint suggests how synergistic crosstalk betwee
150 This Viewpoint summarises the data regarding the use of
151 This Viewpoint summarises the relevant literature over t
152 This viewpoint summarizes some of the major findings in
153 This Viewpoint summarizes the discovery of a highly pote
154 This viewpoint summarizes the discovery of a neutral, po
155 This viewpoint summarizes the discovery of KT-474-a sele
156 This Viewpoint summarizes the discovery of potent and se
157 This viewpoint summarizes the newly reported discovery o
158 This Viewpoint summarizes the strong scientific argument
159 This viewpoint summarizes these imaging trials studying
160 It is
this viewpoint that has shaped the theme for my presiden
161 Two areas of concern are highlighted in
this Viewpoint:
the respective remits of the new bodies
162 Here we apply
this viewpoint to geometry and initiate a program of cla
163 We present
this viewpoint to specifically challenge the carte blanc
164 This viewpoint underscores the urgent need for the ID co
165 This Viewpoint was written in association with the 25th
166 In
this viewpoint we also advocate the incorporation of enh
167 order to come up with a holistic picture, in
this Viewpoint we compare mechanisms and infochemicals i
168 has explored these changes in isolation, in
this Viewpoint we consider them collectively.
169 In
this Viewpoint we describe how to use SoMe platforms (e.
170 In
this Viewpoint we discuss how experimental medicine appl
171 In
this Viewpoint we examine the current guidelines and ear
172 In
this Viewpoint we explain the scientific reasoning behin
173 In
this Viewpoint we reflect on recent disbalance between s
174 In
this Viewpoint we suggest an approach by which the globa
175 In
this Viewpoint we synthesize current knowledge of the an
176 In
this Viewpoint,
we address pharmacokinetic research gaps
177 In
this Viewpoint,
we address some of the limitations withi
178 In
this Viewpoint,
we advance a vision of strong national r
179 In
this Viewpoint,
we advocate for the integration of oral
180 In
this viewpoint,
we aim to demonstrate why the method use
181 In
this Viewpoint,
we aim to initiate a collective effort t
182 In
this Viewpoint,
we aim to review the existing literature
183 In
this Viewpoint,
we aim to: highlight the importance of b
184 In
this Viewpoint,
we analyse cancer vaccine trials, the st
185 In
this Viewpoint,
we analyse the seemingly shared biologic
186 In
this Viewpoint,
we argue that ethical principles and a p
187 In
this Viewpoint,
we argue that feminist-grounded efforts
188 In
this Viewpoint,
we argue that over-the-counter antibioti
189 In
this Viewpoint,
we argue that preventing firearm injury
190 In
this Viewpoint,
we argue that public health researchers
191 In
this Viewpoint,
we argue that pulse oximeters have a cru
192 In
this Viewpoint,
we argue that the current large-scale mo
193 In
this Viewpoint,
we argue that tissue donation following
194 In
this Viewpoint,
we argue that use of the terms benign an
195 In
this Viewpoint,
we argue that we must bring concepts fro
196 In
this Viewpoint,
we argued for the removal of race-based
197 In
this Viewpoint,
we ask if and how the Sustainable Develo
198 In
this Viewpoint,
we asked four expert investigators and m
199 In
this Viewpoint,
we asked four leading experts to provide
200 In
this Viewpoint,
we asked three individuals who have been
201 In
this Viewpoint,
we asked two leading oncologists involve
202 In
this Viewpoint,
we begin by describing the essential fea
203 In
this viewpoint,
we briefly review the status of antiretr
204 In
this Viewpoint,
we call attention to the need and urgenc
205 In
this Viewpoint,
we call for the urgent revision of donor
206 In
this Viewpoint,
we contend that fertility care should be
207 In
this viewpoint,
we contrast the aims, methods, and resul
208 In
this Viewpoint,
we critically appraise and review the li
209 In
this Viewpoint,
we critically examine two premises behin
210 In
this viewpoint,
we describe the content of the abstracts
211 In
this viewpoint,
we describe the LEAP fellowship, its out
212 In
this Viewpoint,
we describe these and related trends in
213 In
this Viewpoint,
we describe these parallel crises, argue
214 In
this Viewpoint,
we discuss how the identification of ora
215 In
this viewpoint,
we discuss our approach to reopening an
216 In
this Viewpoint,
we discuss some of these results, which
217 In
this Viewpoint,
we discuss technological advances in 3D
218 In
this Viewpoint,
we discuss the available evidence from l
219 In
this Viewpoint,
we discuss the epidemiology, pathophysio
220 In
this Viewpoint,
we discuss the important role of impleme
221 In
this Viewpoint,
we discuss the limitations in the curren
222 In
this Viewpoint,
we discuss the need for a holistic under
223 In
this Viewpoint,
we discuss the pathophysiology, risk fac
224 In
this viewpoint,
we discuss the pitfalls that can arise w
225 In
this Viewpoint,
we discuss the relationship between tran
226 In
this Viewpoint,
we discuss the validity of using spleen
227 In
this viewpoint,
we examine the evolving literature on ke
228 In
this Viewpoint,
we explore how failure to consider custo
229 In
this Viewpoint,
we explore how using multiple eco-evolut
230 In
this viewpoint,
we explore some of the barriers to incor
231 In
this Viewpoint,
we explore the biological linkage betwee
232 In
this Viewpoint,
we explore the history of the collective
233 In
this Viewpoint,
we focus on a framework of integrated re
234 In
this Viewpoint,
we focus on the alternative construction
235 In
this Viewpoint,
we focus on two policy challenges of the
236 In
this Viewpoint,
we have asked six oncologists working in
237 In
this Viewpoint,
we have asked three recipients of this a
238 In
this Viewpoint,
we hear from a cross section of women, a
239 In
this viewpoint,
we highlight evidence regarding the incr
240 In
this Viewpoint,
we highlight evidence showing that iron
241 In
this viewpoint,
we highlight the changes in exception po
242 In
this viewpoint,
we highlight the crucial knowledge gaps
243 In
this Viewpoint,
we highlight the regularity with which t
244 In
this viewpoint,
we join recent criticisms of the gene-ce
245 In
this viewpoint,
we narrate our rationale for why cDCDD-N
246 In
this viewpoint,
we narrate the evolving rationale for an
247 In
this Viewpoint,
we outline the need for more accurate me
248 In
this Viewpoint,
we present a focused, pilot, and longitu
249 In
this Viewpoint,
we present a global agenda for child hea
250 In
this Viewpoint,
we present an analytic framework that se
251 In
this Viewpoint,
we present an empirical critique of how
252 In
this Viewpoint,
we present our opinion on the benefits a
253 In
this Viewpoint,
we propose that a more explicit consider
254 In
this Viewpoint,
we propose that inflammation and its con
255 In
this Viewpoint,
we propose that studying plant mutualist
256 In
this viewpoint,
we provide a narrative review of key asp
257 In
this Viewpoint,
we provide a narrative review of landmar
258 In
this viewpoint,
we provide considerations for clinical p
259 In
this Viewpoint,
we report evidence supporting reposition
260 In
this Viewpoint,
we review promising data from ongoing cl
261 In
this viewpoint,
we review the current knowledge regardin
262 In
this Viewpoint,
we review the evidence base for tubercul
263 In
this Viewpoint,
we review the evidence behind the contem
264 In
this Viewpoint,
we review the factors that are likely to
265 In
this Viewpoint,
we review the merits and limitations of
266 In
this Viewpoint,
we review the retrospective and prospect
267 In
this Viewpoint,
we review the specifics of outcome diffe
268 In
this Viewpoint,
we review the unique health challenges f
269 From
this viewpoint,
we reviewed the existing inequalities in
270 In
this Viewpoint,
we seek to advance this agenda by identi
271 In
this Viewpoint,
we seek to consolidate thinking around h
272 vernment-funded national health services, in
this Viewpoint,
we share learning from examples in the U
273 In
this viewpoint,
we share our first-hand experience with
274 In
this Viewpoint,
we show that A albopictus is establishin
275 In
this Viewpoint,
we suggest that the use of lower than ap
276 In
this Viewpoint,
we summarise the characteristics of thes
277 In
this Viewpoint,
we summarize recent evidence for the rol
278 In
this Viewpoint,
we summarize these deliberations and ide
279 In
this Viewpoint,
we take an expansive view of harm reduct
280 In
this Viewpoint,
we take stock of the current state of HI
281 In
this viewpoint,
we use the example of liver transplantat
282 In
this Viewpoint,
we will discuss the Circumspect Awarenes
283 In
this Viewpoint,
we will explore the role of HDM-AHCT in
284 We present the results of this project in
this Viewpoint,
which identify unmet GVHD needs from the
285 In
this Viewpoint,
which is largely focused on high-income
286 guidelines into "cookbooks." We believe that
this viewpoint,
while unequivocally acknowledging the fu
287 This viewpoint will explore the available evidence for a
288 This viewpoint will explore the available evidence for a
289 Further, we hope that publication of
this viewpoint will help temper enthusiasm for overzealo
290 This viewpoint will highlight contemporary AST challenge
291 This Viewpoint will summarise the evidence that suggests